COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:25, il y a 11 mois 28 jours LODD Completes First Flight of Hili - The UAE's First Hybrid Heavy Cargo UAV, Designed, Built and Tested in Abu Dhabi LODD Autonomous completes the first flight of Hili, UAE's first hybrid heavy cargo UAV, in Abu Dhabi during Abu Dhabi Autonomous Week, showcasing advanced autonomous aviation and next-generation cargo logistics Abu Dhabi LODD Autonomous Hili Autonomous Aviation Cargo Logistics
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:09, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.64% interest in Qualcomm Incorporated. Deals involving USD 0.0001 common stock include purchases and sales The Vanguard Group Financial Disclosure Interest Disclosure Stock Dealings Qualcomm Incorporated
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:08, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses holding 7.47% interest in American Axle & Manufacturing Holdings, Inc. as of 12-Nov-2025 Securities Disclosure The Vanguard Group Interests American Axle & Manufacturing Holdings
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:07, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses its position of 5.06% in JTC plc. Details of the holdings and recent dealings provided in Form 8.3 Form 8.3 Position Disclosure The Vanguard Group Inc. Securities Dealing JTC Plc
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:05, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% stake in Avadel Pharmaceuticals plc as of 12 November 2025 under Form 8.3 with Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:05, il y a 11 mois 28 jours SwitchBot AI Art Frame Now Officially Available SwitchBot announces the official launch of the SwitchBot AI Art Frame, the world's first AI-powered Color E-Ink Art Frame for modern homes. Features AI Studio function powered by NanoBanana* for creating original artworks AI Studio SwitchBot AI Art Frame E-Ink NanoBanana
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:05, il y a 11 mois 28 jours Rektron Provides Bi-Weekly Default Status Report Rektron Group Inc. provides bi-weekly default status report under temporary management cease trade order by BC Securities Commission for delayed filings. Company aims to file Annual Filings by December 18, 2025, continuing alternate information guidelines compliance Management Cease Trade Order Annual Filings BC Securities Commission Commodity Trading Rektron Group Inc.
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:04, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc as of 12 Nov 2025. No other parties involved in the offer Irish Takeover Panel The Vanguard Group Financial Disclosure Interest Disclosure Mural Oncology Plc
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:02, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.34% interest in Greencore Group plc's 1p ordinary securities. Disclosure made under Rule 8.3 of the Takeover Code Disclosure Rule 8.3 Takeover Code Vanguard Group Greencore Group Plc
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 16:00, il y a 11 mois 28 jours Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses 1.24% stake in Bluefield Solar Income Fund Limited. Form 8.3 filed on 13 November 2025 Form 8.3 The Vanguard Group Inc. Financial Disclosure Stake Disclosure Bluefield Solar Income Fund Limited
Publié le 12/11/2026 à 08:56, il y a 4 heures 54 minutes Number of shares and voting rights - October 2026 (In French only)
Publié le 12/11/2026 à 08:56, il y a 4 heures 54 minutes Nombre total d'actions et droits de vote - octobre 2026
Publié le 12/11/2026 à 08:40, il y a 5 heures 11 minutes FREY forms a €400 million equity partnership with GIC to invest in premium European retail parks
Publié le 12/11/2026 à 08:40, il y a 5 heures 11 minutes FREY et GIC s’associent pour investir 400 M€ de capital dans les retail parks premium en Europe
Publié le 10/11/2026 à 18:00, il y a 1 jour 19 heures Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Publié le 12/11/2026 à 13:45, il y a 6 minutes Amarc and Freeport Successfully Complete 2026 Joy Copper-Gold District Exploration Program
Publié le 12/11/2026 à 13:30, il y a 21 minutes Nextech3D.ai to Present at the Small Cap Growth Virtual Investor Conference November 18th at 12:30 p.m. ET
Publié le 12/11/2026 à 13:30, il y a 21 minutes AIML Subsidiary NeuralCloud Signs Agreement With MyCor360+ to Integrate MaxYield(TM) into Next-Generation Cardiac Monitoring Device
Publié le 12/11/2026 à 13:30, il y a 21 minutes Meta Critical Minerals Completes High-Resolution LiDAR Survey at Its 100% Owned Table Mountain High-Purity Silica Project, Golden, British Columbia
Publié le 12/11/2026 à 13:29, il y a 22 minutes Impauer Technologies Unveils Frictionless Gasless Transaction Routing for Pauerone Wallet V2
Publié le 12/11/2026 à 13:34, il y a 17 minutes First Rail London uses on IVU.rail for the operation of the London Overground
Publié le 12/11/2026 à 13:20, il y a 31 minutes BALFIN Group Acquires Tietz Property in Munich, Marking Entry into German Market
Publié le 12/11/2026 à 13:17, il y a 34 minutes EQS-Adhoc: Allgeier SE: Allgeier increases revenue by 6 percent and adjusted EBITDA by 8 percent to EUR 14.1 million in the third quarter of 2026 / 2026 guidance confirmed
Publié le 12/11/2026 à 13:12, il y a 39 minutes REPLY: The Board of Directors approves the quarterly financial report as of 30 September 2026
Publié le 12/11/2026 à 13:00, il y a 51 minutes Novogenia to Contribute DNA Analytics and Personalized Dietary Supplements to Planned Clinical Study as Part of the 10XREVIV Initiative